Matches in Wikidata for { <http://www.wikidata.org/entity/Q65465875> ?p ?o ?g. }
Showing items 1 to 35 of
35
with 100 items per page.
- Q65465875 description "clinical trial" @default.
- Q65465875 description "ensayu clínicu" @default.
- Q65465875 description "klinisch onderzoek" @default.
- Q65465875 description "клінічне випробування" @default.
- Q65465875 name "Study to Evaluate the Overall Performance of the Zalviso System™ (Sufentanil Sublingual Tablet System) 15 mcg" @default.
- Q65465875 name "Study to Evaluate the Overall Performance of the Zalviso System™" @default.
- Q65465875 type Item @default.
- Q65465875 label "Study to Evaluate the Overall Performance of the Zalviso System™ (Sufentanil Sublingual Tablet System) 15 mcg" @default.
- Q65465875 label "Study to Evaluate the Overall Performance of the Zalviso System™" @default.
- Q65465875 prefLabel "Study to Evaluate the Overall Performance of the Zalviso System™ (Sufentanil Sublingual Tablet System) 15 mcg" @default.
- Q65465875 prefLabel "Study to Evaluate the Overall Performance of the Zalviso System™" @default.
- Q65465875 P1132 Q65465875-5600AD9E-4140-4EFC-B9A2-FB8083209E78 @default.
- Q65465875 P1476 Q65465875-73A0F211-348C-41D4-880C-D5278A8C61F6 @default.
- Q65465875 P17 Q65465875-8B069C45-DA87-48DE-9E8D-B6B5A76471BB @default.
- Q65465875 P2899 Q65465875-1AC2918D-DB76-4503-AB86-C0C561A73A29 @default.
- Q65465875 P3098 Q65465875-C7C1FA4A-DD95-4684-90FF-EE0FA27E5FAF @default.
- Q65465875 P31 Q65465875-68BF4342-1CFC-42CD-82D9-75D232024151 @default.
- Q65465875 P4844 Q65465875-C88595F0-1908-42D3-8A67-CEE2F687BD71 @default.
- Q65465875 P580 Q65465875-6F29DECA-825D-4809-8F76-F85D2822072D @default.
- Q65465875 P582 Q65465875-5E82A4AB-7ED1-43DD-B362-B1B24A524610 @default.
- Q65465875 P6099 Q65465875-B0013126-FA55-46E3-80CF-18F50E3EFBDF @default.
- Q65465875 P6153 Q65465875-A6604821-BA19-4912-B50E-16BC9B15A28A @default.
- Q65465875 P8363 Q65465875-629115A2-3E6E-4A68-850F-1F3A71C0D083 @default.
- Q65465875 P1132 "+320" @default.
- Q65465875 P1476 "A Multicenter, Open-Label Trial to Evaluate the Overall Performance of the Zalviso System™ (Sufentanil Sublingual Tablet System) 15 mcg" @default.
- Q65465875 P17 Q30 @default.
- Q65465875 P2899 "+18" @default.
- Q65465875 P3098 "NCT02662764" @default.
- Q65465875 P31 Q30612 @default.
- Q65465875 P4844 Q417915 @default.
- Q65465875 P580 "2016-09-28T00:00:00Z" @default.
- Q65465875 P582 "2017-04-14T00:00:00Z" @default.
- Q65465875 P6099 Q42824827 @default.
- Q65465875 P6153 Q30269988 @default.
- Q65465875 P8363 Q78089383 @default.